Skip to main content

Table 1 Demographic details for participants taking part in the unstructured face to face interviews

From: Burden of disease and adaptation to life in patients with Crohn’s perianal fistula: a qualitative exploration

Participant Sex Age Duration of CD (years) Duration of perianal fistula (years) Previous fistula surgery (excluding abscess drainage) Current Stoma Medication for fistula
1 Male 26 13 4 Yes Yes Nil
2 Female 26 4 1 Yes No Antibiotics – cyclical
3 Female 34 14 5 Yes Yes Nil
4 Male 23 5 3 Yes No Anti-TNF
5 Male 23 2 2 Yes No Nil
6 Female 16 2 0.5 no No Nil
7 Female 39 5 5 Yes No Anti-TNF
8 Female 52 9 7 Yes No Anti-TNF
9 Female 37 6 2 Yes No AZT
10 Female 35 15 1 Yes No Anti-TNF + AZT
11 Female 43 19 14 Yes No Anti-TNF + AZT
12 Female 20 3 3 Yes No Anti-TNF + AZT
  1. AZT Azathioprine, anti-TNF – biologic medication, specifically anti-TNF alpha drugs (infliximab / adalimumab), nil none